Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 9.6 CNY -1.54% Market Closed
Market Cap: 4.2B CNY

Intrinsic Value

The intrinsic value of one Hunan Fangsheng Pharmaceutical Co Ltd stock under the Base Case scenario is 15.09 CNY. Compared to the current market price of 9.6 CNY, Hunan Fangsheng Pharmaceutical Co Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15.09 CNY
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Hunan Fangsheng Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Hunan Fangsheng Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hunan Fangsheng Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
CN
Pharmaceuticals
Market Cap
4.2B CNY
IPO
Dec 5, 2014
CN
Pharmaceuticals
Market Cap
4.2B CNY
IPO
Dec 5, 2014
Price
ÂĄfalse
EPS
ÂĄfalse
Hunan Fangsheng Pharmaceutical Co Ltd
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hunan Fangsheng Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hunan Fangsheng Pharmaceutical Co Ltd

Current Assets 1B
Cash & Short-Term Investments 212m
Receivables 359.7m
Other Current Assets 473m
Non-Current Assets 2.2B
Long-Term Investments 241.4m
PP&E 1.2B
Intangibles 529.3m
Other Non-Current Assets 295m
Efficiency

Free Cash Flow Analysis
Hunan Fangsheng Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hunan Fangsheng Pharmaceutical Co Ltd

Revenue
1.8B CNY
Cost of Revenue
-541.1m CNY
Gross Profit
1.2B CNY
Operating Expenses
-970.2m CNY
Operating Income
250.3m CNY
Other Expenses
22.7m CNY
Net Income
273m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hunan Fangsheng Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive Revenue Growth Forecast
Positive 3-Year Average ROE
57/100
Profitability
Score

Hunan Fangsheng Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hunan Fangsheng Pharmaceutical Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
53/100
Solvency
Score

Hunan Fangsheng Pharmaceutical Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hunan Fangsheng Pharmaceutical Co Ltd

Wall Street analysts forecast Hunan Fangsheng Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hunan Fangsheng Pharmaceutical Co Ltd is 13.96 CNY with a low forecast of 12.66 CNY and a high forecast of 15.59 CNY.

Lowest
Price Target
12.66 CNY
32% Upside
Average
Price Target
13.96 CNY
45% Upside
Highest
Price Target
15.59 CNY
62% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hunan Fangsheng Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hunan Fangsheng Pharmaceutical Co Ltd stock?

The intrinsic value of one Hunan Fangsheng Pharmaceutical Co Ltd stock under the Base Case scenario is 15.09 CNY.

Is Hunan Fangsheng Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 9.6 CNY, Hunan Fangsheng Pharmaceutical Co Ltd is Undervalued by 36%.

Back to Top